| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.244 | 14.408 | 23.199 | 21.940 | 27.297 | 2.832 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 11.244 | 14.408 | 23.199 | 21.940 | 27.297 | 2.832 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 8.494 | 6.757 | 12.245 | 13.995 | 14.099 | 3.928 | 2.474 | 2.195 | 2.416 | 76 |
| Gross Profit/Loss - EUR | 2.750 | 7.651 | 10.954 | 7.945 | 13.199 | -1.095 | -2.474 | -2.195 | -2.416 | -76 |
| Net Profit/Loss - EUR | 2.412 | 7.219 | 10.005 | 7.286 | 12.380 | -1.180 | -2.474 | -2.195 | -2.416 | -76 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Deus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 528 | 437 | 18.044 | 15.235 | 12.545 | 10.069 | 7.658 | 5.487 | 3.282 | 3.264 |
| Current Assets | 3.639 | 10.890 | 14.921 | 7.349 | 24.083 | 22.562 | 21.306 | 21.372 | 21.266 | 15.984 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 22 | 15 | 10.172 | 6.571 | 22.256 | 21.697 | 21.216 | 21.282 | 21.217 | 15.911 |
| Cash | 3.617 | 10.875 | 4.749 | 778 | 1.827 | 865 | 91 | 91 | 49 | 73 |
| Shareholders Funds | 3.883 | 11.056 | 16.380 | 9.793 | 21.983 | 20.386 | 17.461 | 15.320 | 12.857 | 12.710 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 283 | 271 | 16.585 | 12.791 | 14.644 | 12.245 | 11.504 | 11.539 | 11.690 | 6.538 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Deus Med S.r.l.